Scandion Oncology A/S (SCOL) — Defensive Interval Ratio
Scandion Oncology A/S (SCOL) has a Defensive Interval Ratio of 29 days as of December 2024. Defensive assets of Skr807.00K (cash Skr-, short-term investments Skr-, receivables Skr807.00K) cover 29 days of daily cash needs of Skr27.43K/day. See Scandion Oncology A/S current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Scandion Oncology A/S Defensive Interval Ratio (2017–2024)
This chart shows how Scandion Oncology A/S's Defensive Interval Ratio has evolved across 6 annual periods from 2017 to 2024. As of December 2024, the ratio stands at 29 days, meaning defensive assets of Skr807.00K can fund 29 days of operations without new revenue. See SCOL net asset quality score to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Scandion Oncology A/S (2017–2024)
The table below presents the year-by-year Defensive Interval Ratio for Scandion Oncology A/S from 2017 to 2024, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Scandion Oncology A/S market capitalisation.
| Year | DIR (days) | Defensive Assets (SEK) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 29 days | Skr807.00K | Skr27.43K/day | Skr- | Skr- | ▼ -218 days |
| 2021 | 247 days | Skr7.52 Million | Skr30.39K/day | Skr- | Skr- | ▲ +177 days |
| 2020 | 70 days | Skr5.80 Million | Skr82.26K/day | Skr- | Skr- | ▼ -922 days |
| 2019 | 993 days | Skr3.97 Million | Skr4.00K/day | Skr- | Skr- | ▲ +252 days |
| 2018 | 741 days | Skr2.02 Million | Skr2.72K/day | Skr- | Skr- | ▲ +546 days |
| 2017 | 196 days | Skr272.79K | Skr1.39K/day | Skr- | Skr- | — |